BSE Live
Sep 05, 16:01Prev. Close
3325.75
Open Price
3318.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 05, 15:51Prev. Close
3319.40
Open Price
3309.00
Bid Price (Qty.)
3249.60 (7)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of Dr Lal PathLabs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 2,351.44 | 1,966.62 | 1,768.79 | 1,872.58 | 1,490.47 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 2,351.44 | 1,966.62 | 1,768.79 | 1,872.58 | 1,490.47 | |
Total Operating Revenues | 2,351.62 | 1,966.76 | 1,769.03 | 1,872.71 | 1,490.56 | |
Other Income | 111.52 | 60.11 | 46.60 | 53.02 | 51.27 | |
Total Revenue | 2,463.14 | 2,026.86 | 1,815.63 | 1,925.72 | 1,541.82 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Operating And Direct Expenses | 455.24 | 390.76 | 389.64 | 446.32 | 373.90 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Employee Benefit Expenses | 457.54 | 363.59 | 315.50 | 320.22 | 257.44 | |
Finance Costs | 21.50 | 26.84 | 34.38 | 28.53 | 14.83 | |
Depreciation And Amortisation Expenses | 134.15 | 76.54 | 82.09 | 75.31 | 69.78 | |
Other Expenses | 773.43 | 653.17 | 603.19 | 595.95 | 451.84 | |
Total Expenses | 1,841.86 | 1,510.89 | 1,424.80 | 1,466.33 | 1,167.78 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 621.28 | 515.97 | 390.83 | 459.39 | 374.04 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 621.28 | 515.97 | 390.83 | 459.39 | 374.04 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 163.34 | 137.58 | 101.44 | 118.01 | 98.43 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | -39.32 | -5.98 | -2.97 | -2.67 | -4.49 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 124.02 | 131.60 | 98.47 | 115.34 | 93.94 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 497.26 | 384.37 | 292.36 | 344.05 | 280.11 | |
Profit/Loss From Continuing Operations | 497.26 | 384.37 | 292.36 | 344.05 | 280.11 | |
Profit/Loss For The Period | 497.26 | 384.37 | 292.36 | 344.05 | 280.11 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 59.70 | 46.25 | 35.28 | 41.61 | 33.93 | |
Diluted EPS (Rs.) | 59.61 | 46.18 | 35.17 | 41.48 | 33.85 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 199.91 | 199.48 | 99.43 | 115.71 | 99.11 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 240.00 | 240.00 | 120.00 | 120.00 | 200.00 |
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
22.07.2025
23.06.2025
Dr Lal PathLabs, Metropolis, others fall up to 2% as Amazon launches home diagnostics services
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
25.04.2025
Dr Lal PathLab Standalone March 2025 Net Sales at Rs 577.20 crore, up 20.5% Y-o-Y
25.04.2025
Dr Lal PathLab Consolidated March 2025 Net Sales at Rs 602.60 crore, up 10.49% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak